U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774819) titled 'Spatially Fractionated Radiotherapy for Tumor Treatment' on July 11.
Brief Summary: To explore the efficacy and toxicity of spatially fractionated radiotherapy in the treatment of tumors.
Study Start Date: Dec. 19, 2024
Study Type: INTERVENTIONAL
Condition:
Radiotherapy-Induced Immune Priming
Intervention:
RADIATION: spatially fractionated radiotherapy
spatially fractionated radiotherapy
Recruitment Status: RECRUITING
Sponsor: Xu Zhi-yuan
Information provided by (Responsible Party): Xu Zhi-yuan, The University of Hong Kong-Shenzhen Hospital
Disclaimer: Curated by HT Syndication....